Resource

A Novel Mechanism for Enhancing Checkpoint Blockade in Cancer Immunotherapy - sCTLA-4 LAG-3 may Serve as a Potential Therapeutic Target for Tau Protein Disorders Recent Innovations in Immune Checkpoint Assay Technologies A New Mechanism of Lactate Regulation of Immune Checkpoint Expression What is Immune Checkpoint What is PD1 What is HHLA2 What is GITRL B7-H3 ADC LAG-3 Inhibitor in Cancer Intracellular Immune Checkpoint – PTP1B Emerging Immune Checkpoints - DDRs Emerging Immune Checkpoints - ART1 Toxicity of Immune Checkpoint Inhibitors Emerging Immune Checkpoints - ILDR2 B-Cell Immune Checkpoint - TIM-1 Immune Checkpoints of NK Cell Ligands for Common Immune Checkpoints New Immune Checkpoint for Cancer Therapy: Siglec Receptor Cell Analysis Methods for Immune Checkpoint Studies Molecular Imaging for Immune Checkpoint Research Common Cell Lines Used for Immune Checkpoint Inhibitor Screening Glycosylation of Immune Checkpoints MDSC Immune Checkpoint - c-Rel Immune Checkpoint Therapy in Macrophage PD-L1 VS PD-1 Regimens of Immune Checkpoint Inhibitors in Combination with ADCs Identification and Study of Immune Checkpoints in Circulating Tumor Cells New Immune Checkpoint in Macrophage - SLAMF3/4 Natural Compounds Targeting Immune Checkpoint Proteins Emerging Immune Checkpoints - ADRB1 Emerging Immune Checkpoints - BCL-2 Mutual Regulation of Immune Checkpoints Emerging Immune Checkpoints - ROR1 Immune Checkpoints in T Cell Priming and Activation ADAM17 as A Regulatory Checkpoint for CD16A in NK Cells Probiotic Metabolites Effectively Promote Immune Checkpoints for Antitumor Therapy m6A Modification Enhances Immune Checkpoint Therapy Exploring Spatial Distribution of Immune Checkpoints with Cutting-Edge Techniques Advances in Small Molecule Drugs Targeting PD-1/PD-L1 A Secreted Immune Checkpoint - IL-18BP A Metabolic Immune Checkpoint - IL4I1 CAR-T with Half CTLA-4 New Insights into the Molecular Structure of LAG-3 HER-3 ADC Research and Development Progress Advances in Immune Checkpoint TIGIT in Tumors Intracellular Immune Checkpoints - SHP-2, CBL-b, CISH, HPK1 Target NR2F6: Immune Checkpoint and Regulate T Cell Differentiation and Exhaustion Two Hot Targets: FGFR4 and HPK1

All listed customized services & products are for research use only, not intended for pharmaceutical, diagnostic, therapeutic, or any in vivo human use.

USA

Tel:

Fax:

Email:

Europe

Global Locations